The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Leadership - Radius Health
Honoraria - AstraZeneca; Camel-IDS; Crescendo Biologics; Debiopharm Group; G1 Therapeutics; HUYA Bioscience International; Immunomedics; Lilly; Menarini; MSD; Novartis; Odonate Therapeutics; Oncolytics; Periphagen; Pfizer; PharmaMar (I); Roche/Genentech; Seagen
Consulting or Advisory Role - AstraZeneca; Camel-IDS; Crescendo Biologics; Debiopharm Group; G1 Therapeutics; HUYA Bioscience International; Immunomedics; Lilly; Menarini; MSD; Novartis; Odonate Therapeutics; Oncolytics; Periphagen; Pfizer; PharmaMar; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Roche/Genentech (Inst); SERVIER (Inst); Synthon (Inst)
 
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Roche

ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early-stage triple-negative breast cancer.
 
Heather L. McArthur
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech; Genomic Health; Immunomedics; Lilly; Merck; Pfizer; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); ZIOPHARM Oncology (Inst)
Travel, Accommodations, Expenses - Amgen; Genentech; Immunomedics; Lilly; Lilly; Lilly; Lilly; Merck; Pfizer; Puma Biotechnology; Spectrum Pharmaceuticals
Other Relationship - Lilly; OBI Pharma
 
Michail Ignatiadis
Consulting or Advisory Role - Celgene; Novartis; Pfizer; Seagen; Tesaro
Research Funding - Janssen Diagnostics (Inst); Menarini Silicon Biosystems (Inst); Pfizer; Roche (Inst)
Patents, Royalties, Other Intellectual Property - Patent entitled method for determining sensitivity to a CDK4/6 inhibitor
Travel, Accommodations, Expenses - Pfizer (I)
 
Sebastian Guillaume
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Andrew Bailey
No Relationships to Disclose
 
Jorge Luis Martinez
Employment - Roche
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Mariana Brandao
No Relationships to Disclose
 
Otto Metzger
Honoraria - Roche
Research Funding - Abbvie (Inst); Genentech (Inst); Pfizer (Inst); Roche (Inst)
 
Catherine Lai
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche/Genentech
Research Funding - Genentech/Roche
 
Debora Fumagalli
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); SERVIER (Inst); Tesaro (Inst)
 
Fergus Daly
No Relationships to Disclose
 
Aicha Bouhlel
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Valeria Karusinova
Employment - ASIT Biotech
Research Funding - Genentech; Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Genentech; Roche
 
Christie Freeman
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Giuseppe Viale
Honoraria - MSD Oncology; Pfizer
Consulting or Advisory Role - Astellas Pharma; Dako; Novartis; Roche/Genentech
Research Funding - Dako/Agilent Technologies (Inst); Roche/Genentech; Ventana Medical Systems (Inst)
Travel, Accommodations, Expenses - Celgene; Roche; Roche
 
Vanessa Honvault
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Carter Dufrane
No Relationships to Disclose
 
Anh Nguyen Duc
Employment - Roche
 
Martine J. Piccart
No Relationships to Disclose
 
Eric S. Winer
Stock and Other Ownership Interests - Verastem
Honoraria - Carrick Therapeutics; Genentech/Roche; GlaxoSmithKline; Lilly; Tesaro
Consulting or Advisory Role - Leap Therapeutics
 
Richard D. Gelber
Research Funding - AstraZeneca (Inst); Celgene (Inst); Ferring (Inst); Ipsen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)